Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Entero Therapeutics, Inc.

Home Clinical Trial Sponsors and OrganizationsEntero Therapeutics, Inc.

Entero Therapeutics, Inc.

ACTIVE

777 W Yamato Rd Ste 502, 佛罗里达州棕榈滩县, 佛罗里达州, United Statesenterothera.comPublic9 employeesEstablished: 2014-01-01

Also known as:

FWBI

first wave biopharma, inc.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

2

2 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2014

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

2

100.0%

Trial Status Distribution

Active, not recruiting

2

100.0%

Clinical Trials

Trials sponsored by this organization (2)

Phase I/IIa, three-stage study to investigate the safety, the efficacy and the pharmacokinetics of niclosamide enemas in subjects with active ulcerative proctitis or ulcerative procto-sigmoiditis

Active, not recruiting

Jan 2021105 participants

A three-stage clinical trial to assess the safety, the effect and the pharmacokinetics of the drug niclosamide in the treatment of patients with the condition ulcerative proctitis or ulcerative procto-sigmoiditis

Active, not recruiting

Dec 2020105 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials2
Approvals
News

Back to Organizations